Evidence map›Paper›PMID 34508572›Full record

SynthesisJournal of Crohn's & colitis2022

The Relationship Between Endoscopic and Clinical Recurrence in Postoperative Crohn's Disease: A Systematic Review and Meta-analysis.

Alessandro Ble, Cecilia Renzulli, Fabio Cenci, Maria Grimaldi, Michelangelo Barone, Rocio Sedano, Joshua Chang, Tran M Nguyen, Malcolm Hogan, Guangyong Zou and 6 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of Crohn's & colitis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Incidence, risk factors and preventive strategies for post-operative recurrence of Crohn's disease: A retrospective propensity-matched cohort analysis.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Case Report: Managing Postoperative Crohn's Disease.Gastroenterology & hepatology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Alessandro BleCorporate R&D, Alfasigma S.p.A., Bologna, Italy.
Cecilia RenzulliCorporate R&D, Alfasigma S.p.A., Bologna, Italy.
Fabio CenciCorporate R&D, Alfasigma S.p.A., Bologna, Italy.
Maria GrimaldiCorporate R&D, Alfasigma S.p.A., Bologna, Italy.
Michelangelo BaroneCorporate R&D, Alfasigma S.p.A., Bologna, Italy.
Rocio SedanoAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.
Joshua ChangAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.
Tran M NguyenAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.
Malcolm HoganAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.ORCID 0000-0003-0676-9673
Guangyong ZouAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.
John K MacDonaldAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.
Christopher MaAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.ORCID 0000-0002-4698-9948
William J SandbornAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.
Brian G FeaganAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.
Emilio Merlo PichCorporate R&D, Alfasigma S.p.A., Bologna, Italy.
Vipul JairathAlimentiv Inc. [formerly Robarts Clinical Trials], London, ON, Canada.ORCID 0000-0001-8603-898X

Funding

San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LARS ECKMANN, Bernd G. Schnabl · 2019 to 2026
$10.8M
NIDDK NIH HHS P30 DK120515
6 · The paper itself

Abstract

BACKGROUND AND

aimsWe aimed to quantify the magnitude of the association between endoscopic recurrence and clinical recurrence [symptom relapse] in patients with postoperative Crohn's disease.

methodsDatabases were searched to October 2, 2020, for randomised controlled trials [RCTs] and cohort studies of adult patients with Crohn's disease with ileocolonic resection and anastomosis. Summary effect estimates for the association between clinical recurrence and endoscopic recurrence were quantified by risk ratios [RR] and 95% confidence intervals [95% CI]. Mixed-effects meta-regression evaluated the role of confounders. Spearman correlation coefficients were calculated to assess the relationship between these outcomes as endpoints in RCTs. An exploratory mixed-effects meta-regression model with the logit of the rate of clinical recurrence as the outcome and the rate of endoscopic recurrence as a predictor was also evaluated.

resultsIn all, 37 studies [N = 4053] were included. For eight RCTs with available data, the RR for clinical recurrence for patients who experienced endoscopic recurrence was 10.77 [95% CI 4.08 to 28.40; GRADE moderate certainty evidence]; the corresponding estimate from 11 cohort studies was 21.33 [95% CI 9.55 to 47.66; GRADE low certainty evidence]. A single cohort study showed a linear relationship between Rutgeerts score and clinical recurrence risk. There was a strong correlation between endoscopic recurrence and clinical recurrence treatment effect estimates as trial outcomes [weighted Spearman correlation coefficient 0.51].

conclusionsThe associations between endoscopic recurrence and subsequent clinical recurrence lend support to the choice of endoscopic recurrence to monitor postoperative disease activity and as a primary endpoint in clinical trials of postoperative Crohn's disease.

Indexed as

Crohn DiseaseAdultAnastomosis, SurgicalCohort StudiesEndoscopyHumansRecurrenceclinical recurrenceendoscopic recurrencePostoperative Crohn’s disease

Identifiers

PMID34508572
PMCPMC8919832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.